V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001463 | 230007927 | 1.62 | null | null | null | 2021-04-01 | null | null | null | CARBOPLATIN + PACLITAXEL | 100617032 |
| 230001471 | 230007932 | 1.62 | null | null | null | 2021-06-10 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101308405 |
| 230001473 | 230007934 | 1.58 | null | null | null | 2019-06-21 | null | null | null | CISPLATIN | 100088701 |
| 230001488 | 230007939 | 1.55 | 53 | null | 2020-01-25 | 2020-02-01 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100169435 |
| 230001494 | 230007942 | 1.6 | 69.5 | null | 2020-08-01 | 2021-02-21 | DOXORUBICIN | null | null | OLAPARIB | 101092917 |
| 230001497 | 230007944 | 1.63 | 73 | null | 2019-09-25 | 2019-09-29 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | IPILIMUMAB + NIVOLUMAB | 101416217 |
| 230001499 | 230007945 | null | null | null | 2017-12-31 | 2018-01-12 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100260155 |
| 230001502 | 230007947 | 1.5 | 47.1 | Palliative (P) | null | 2020-09-27 | null | null | N | CISPLATIN | 100721791 |
| 230001504 | 230007948 | 1.65 | 81.2 | null | 2018-08-14 | 2018-08-24 | Ipilimumab | N | null | PEMBROLIZUMAB | 100267050 |
| 230001513 | 230007952 | 1.71 | 67.8 | null | 2020-06-24 | 2020-07-06 | null | 01 | null | PEMBROLIZUMAB | 100720261 |
| 230001515 | 230007954 | 1.62 | 51.8 | null | 2020-12-06 | 2021-01-11 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100721315 |
| 230001516 | 230007955 | 1.64 | 104.8 | null | 2018-03-08 | 2018-03-10 | null | 01 | null | CARBOPLATIN + GEMCITABINE | 100349291 |
| 230001522 | 230007959 | 1.62 | 77.1 | null | null | 2018-05-01 | null | null | null | PACLITAXEL | 100092317 |
| 230001527 | 230007961 | null | null | null | 2020-02-17 | 2020-02-23 | null | 02 | null | CISPLATIN + ETOPOSIDE | 100351779 |
| 230001528 | 230007962 | null | null | Palliative (P) | 2018-04-07 | 2018-04-12 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100311026 |
| 230001531 | 230007964 | null | null | null | 2017-07-26 | 2017-08-06 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101373631 |
| 230001534 | 230007965 | 1.65 | 51 | Palliative (P) | 2017-04-05 | 2017-04-20 | Olaparib | 02 | N | OLAPARIB | 100827891 |
| 230001535 | 230007966 | 1.6 | 56.2 | Adjuvant (A) | 2018-04-04 | 2018-11-29 | Bevacizumab | 02 | null | BEVACIZUMAB | 100476314 |
| 230001543 | 230007970 | 1.5 | 79.7 | Palliative (P) | 2017-01-10 | 2017-01-31 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100021021 |
| 230001547 | 230007971 | null | null | null | null | 2019-05-27 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100080866 |
| 230001548 | 230007972 | 1.7 | 72 | Neo-adjuvant (N) | null | 2021-01-05 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100606675 |
| 230001549 | 230007973 | 1.61 | 71.3 | Palliative (P) | 2017-10-28 | 2019-03-15 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100038890 |
| 230001551 | 230007974 | 1.6 | 82.9 | null | 2021-01-21 | 2021-01-21 | null | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101106170 |
| 230001558 | 230007977 | 1.6 | 66.2 | null | null | 2017-07-01 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101092273 |
| 230001559 | 230007978 | null | null | Adjuvant (A) | null | null | null | null | N | OLAPARIB | 101050202 |
| 230001561 | 230007980 | 1.63 | null | null | 2019-03-23 | 2019-03-28 | null | null | null | BEVACIZUMAB | 101444813 |
| 230001565 | 230007982 | null | null | null | 2019-04-19 | 2019-05-23 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101673037 |
| 230001567 | 230007983 | 1.68 | 63.5 | null | 2021-02-06 | 2021-02-15 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101215167 |
| 230001568 | 230007984 | 1.57 | 56 | null | 2016-12-10 | 2016-12-10 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100179612 |
| 230001570 | 230007985 | null | null | Neo-adjuvant (N) | null | 2019-10-15 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100032662 |
| 230001572 | 230007987 | 1.5 | 72 | Palliative (P) | 2020-08-17 | 2020-08-18 | Liposomal Doxorubicin (Caelyx) | 02 | Y | LIPOSOMAL DOXORUBICIN | 101648060 |
| 230001575 | 230007988 | null | null | Curative (C) | null | 2022-03-18 | null | 02 | N | DICE TRIAL | 101263009 |
| 230001576 | 230007989 | null | null | Palliative (P) | null | 2020-01-21 | CARBOPLATIN + GEMCITABINE | N | N | BEVACIZUMAB | 100457086 |
| 230001583 | 230007994 | 1.64 | 66.55 | null | null | 2020-02-16 | Cisplatin + Radiotherapy | 02 | null | DACARBAZINE | 100144511 |
| 230001584 | 230007995 | null | null | null | 2020-01-01 | 2020-01-16 | Bevacizumab 7.5mg/kg | 02 | null | PEMBROLIZUMAB | 101728499 |
| 230001585 | 230007996 | null | null | Palliative (P) | 2022-03-03 | 2022-03-14 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101539767 |
| 230001586 | 230007997 | 1.65 | 54.3 | null | 2017-08-24 | 2018-02-06 | null | null | null | CARBOPLATIN + GEMCITABINE | 101071520 |
| 230001587 | 230007998 | 1.68 | 56.5 | null | null | 2021-11-04 | Niraparib | 02 | null | NIRAPARIB | 101836585 |
| 230001588 | 230007999 | null | null | null | null | 2019-04-16 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100263283 |
| 230001592 | 230008002 | 1.62 | 62.6 | null | 2018-04-21 | 2018-04-30 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101302158 |
| 230001595 | 230008004 | 1.62 | 95 | Palliative (P) | null | 2020-02-11 | null | 02 | N | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100293287 |
| 230001597 | 230008005 | 1.6 | 90 | Palliative (P) | null | 2019-04-05 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101314662 |
| 230001598 | 230008006 | null | null | null | 2022-02-09 | 2022-02-09 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100981348 |
| 230001607 | 230008011 | 1.65 | 47.8 | null | 2019-04-20 | 2019-04-27 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100677787 |
| 230001609 | 230008013 | 1.56 | 53.1 | null | 2017-04-12 | 2017-04-18 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100246118 |
| 230001611 | 230008014 | 1.66 | 113.5 | null | null | 2018-10-17 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100754810 |
| 230001613 | 230008015 | null | null | null | 2018-12-17 | 2018-12-18 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101672262 |
| 230001615 | 230008016 | 1.61 | 55.9 | Palliative (P) | 2020-01-01 | 2020-01-15 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100880549 |
| 230001616 | 230008017 | null | null | Palliative (P) | null | 2020-05-17 | Rucaparib | 02 | N | RUCAPARIB | 100505611 |
| 230001619 | 230008018 | null | null | Palliative (P) | null | 2018-11-29 | Bevacizumab | 02 | N | BEVACIZUMAB | 100638430 |